Takeda sees new Rozerem tact pay off
The whimsical consumer campaign for Takedas insomnia drug Rozerem has generated lots of buzz, but not the kind of recognition that generally leads to new patient starts.
Your Email Address:
Recipient(s) Email Address:
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
Include a message (optional):
The e-mail address(es) that you supply to use this service will only be used to send the requested article.